伐木累

Flu, RSV starting to circulate but cases remain lower than last year: CDC_我的网站

A |     Influenza and other respiratory viruses are starting to circulate but so far remain lower than this time last year, according to the Centers for Disease Control and Prevention.As of Oct. 7, CDC's FluView weekly report showed that the percent of flu cases were relatively unchanged, rising about 1% compared to the week prior.In that same timeframe, 1,127 people were hospitalized with influenza, up from 1,050 people the week prior. About 35% of all flu hospitalizations were reported in the southeast of the U.S., which experts say is a typical trend at the start of the flu season.Most of the flu cases detected were Influenza A and the most common subtype was Influenza A(H1N1), which is the strain of the virus that the flu vaccine usually offers better protection from, according to the CDC.The percent of all reported respiratory viruses circulating over the past week have been relatively unchanged nationally, but there is regional variability. Region 9 -- made up of Arizona, California, Hawaii, and Nevada -- was the only region that saw an increase.Still, the numbers in all regions of the U.S. remain below their baseline and outpatient respiratory illness activity is either minimal or low throughout most of the U.S., according to the CDC.Alaska is the only state that is currently experiencing moderate respiratory illness activity. Influenza typically circulates this time of year and peaks between December and February for most of the U.S., according to the CDC.Respiratory syncytial virus (RSV) numbers are on the rise and are projected to increase further, according to the CDC's weekly surveillance. RSV typically circulates from October to April, according to the CDC.

How to prepare for this year's cold and flu season

This time last year, the U.S. was bracing for a "tripledemic" amid rising cases of COVID-19, influenza and RSV after the seasons became more unpredictable during the COVID-19 pandemic.Dr. John Brownstein, chief innovation officer at Boston Children's Hospital and an ABC News contributor, said these early cases are behaving in a more predictable pattern."The data is pointing to something a little bit more par for the course. We're seeing the early rise of RSV and flu at a time when you'd expect it," Brownstein said.Brownstein, however, cautioned that cases of respiratory viruses are expected to increase further and higher levels still have potential to strain health systems and cause severe illnesses, Brownstein said."I think there's still concern around the threat of all three respiratory viruses plus, of course, the rest of the seasonal mix [of viral illnesses], wreaking havoc on our health systems," he said.Experts are hopeful that new and updated immunizations that protect against COVID-19, influenza and RSV will stave off the strain on health care systems.These viruses may only cause mild illness for many people, but young babies, pregnant women, people who are immunocompromised and the elderly are at highest risk for severe disease.Everyone 6 months and older is eligible for an updated COVID-19 shot and the annual flu vaccine.The Department of Health and Human Services told ABC News that, so far, more than 7 million updated COVID-19 shots have been administered. The CDC recommends getting the COVID-19 and flu vaccines by the end of October and encourages both to be given at the same time.Adults who are 60 years and older can get an RSV vaccine and pregnant women who are in their third trimester can get an RSV shot that provides protection against RSV to their baby for the first 6 months of life.Babies less than 8 months old who are born to mothers who did not get an RSV vaccine during pregnancy can get a protective shot called nirsevimab that offers about five months of protection against RSV.Nirsevimab is a one-dose shot made of monoclonal antibodies, which are proteins manufactured in a lab and mimic the antibodies the body naturally creates when fighting an infection. This is different than a vaccine, which activates the immune system.Brownstein said the pandemic has helped make many health systems better prepared for seasonal spikes in respiratory viruses and is hopeful that people are more motivated to stay up to date on shots that are available for protection and prevention this respiratory virus season."Now is really the time to get the protection advanced of the seasons really heating up," Brownstein said.Dr. Jade A Cobern, M.D., M.P.H, a licensed and practicing physician, is a member of the ABC News Medical Unit.。    　　8月25日晚间，A股上市公司艾可蓝(300816)发布公告称，公司近日与算力客户A公司签署了《算力资源服务合同》，公司向算力客户提供算力服务项目及相关配套设施，合同服务期为60个月，合同总金额为11.09亿元。　　公司表示，本次合同签订有利于公司与头部AI客户在智算领域建立长期合作关系，加快智慧板块布局，并积累大集群运维与头部客户服务经验；有利于优化公司业务结构，提升公司综合竞争力，对公司长期可持续发展具备积极作用。　　对于公司业绩影响方面，公司表示，本合同的顺利履行预计将对公司2026年度经营业绩及未来经营发展产生积极影响。公司将根据本合同履约义务以及收入确认原则在相应的会计期间确认收入，具体会计处理以及对公司经营业绩的影响情况需以审计机构年度审计确认后的结果为准。　　艾可蓝属于发动机尾气后处理行业，产品主要应用于轻型商用柴油车、燃油/混动乘用车和船舶等。近年来，公司逐渐发力智慧板块，开展算力租赁、AI医疗等业务。　　在此前接待机构投资者调研时，艾可蓝曾提到，公司在智慧领域围绕高性能智算和智慧+搭建了三大平台，AI+医疗业务实现了从技术储备到场景落地的转型，通过战略合作切入医疗数据处理业务，完成医药数据智能标准化治理体系，上线智能化数据决策支持平台，验证了多个医疗项目可行性，同时高性能定制化智算服务器业务顺利开展，与参股公司合作迭代产品，相关产品获得沐曦GPU兼容官方认证，为新业务增长打开了空间。　　为了促进新兴业务拓展，增强市场竞争力，公司8月25日晚间还发布公告称，公司拟向供应商采购高性能算力服务器等硬件设备，并签署相关采购合同，采购合同总金额预计不超10亿元。

B | 　　爱建证券认为，艾可蓝逐步重视汽油机尾气处理装置市场，聚焦船舶环保业务，开拓算力租赁和AI医疗等智慧业务，有望成为公司新的利润增长点。汽车尾气处理方面，公司在轻型柴油机市场具有一定比重的市占率，且逐步重视市场规模更大的汽油机市场和海外市场，随着客户拓展，汽油机相关业务有望为公司贡献较大的收入和利润增量。船舶环保业务方面，全球新造船市场活跃，公司聚焦船舶环保业务，2025年公司船舶业务明显扩大，后续船舶业务业绩有望保持较高增速。智慧业务方面，公司与参股公司上海燚智深度合作，于2024年上线算力租赁平台，算力服务器贸易有望贡献一定业绩增量；公司控股公司上海燚健和艾昆纬在医疗智能化领域深入合作，有望成为公司新的利润增长点。（文章来源：证券时报网）。

Current article:http://t4kd95.nuanfanggushuazenxiachuan.buzz/t23/hr0.html

Published on:09:38:00